On December 26, Gelonghui reported that Wanbangde Pharmaceutical Holding Group (002082.SZ) recently stated during an investor relations event that the company's South African operations mainly involve the agency and maintenance services for Medical Devices from Temic and orthopedic implant Medical Devices from Ailite, accounting for about 25% of income.
万邦德(002082.SZ)：南非产业收入占比约为25%左右
Wanbangde Pharmaceutical Holding Group (002082.SZ): The revenue from the South African industry accounts for approximately 25%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated